Literature DB >> 17975905

Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness.

Kjeld Madsen1, Lotte Bjerre Knudsen, Henrik Agersoe, Per Franklin Nielsen, Henning Thøgersen, Michael Wilken, Nils Langeland Johansen.   

Abstract

We here report a series of derivatives describing the structure-activity relationship around liraglutide, a once-daily human glucagon-like peptide-1 fatty acid derivative, with respect to potency as well as protraction in vivo. The spacer region between the fatty acid and the peptide is mostly important for potency, whereas the fatty acid or fatty acid mimetic is important for both potency and protraction. The length of the fatty acid is the most important parameter for protraction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975905     DOI: 10.1021/jm070861j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  70 in total

1.  Extending residence time and stability of peptides by protected graft copolymer (PGC) excipient: GLP-1 example.

Authors:  Gerardo M Castillo; Sandra Reichstetter; Elijah M Bolotin
Journal:  Pharm Res       Date:  2011-08-04       Impact factor: 4.200

2.  Position and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues.

Authors:  Veronika Mäde; Kathrin Bellmann-Sickert; Anette Kaiser; Jens Meiler; Annette G Beck-Sickinger
Journal:  ChemMedChem       Date:  2014-08-22       Impact factor: 3.466

3.  Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency.

Authors:  Paolo Ingallinella; Elisabetta Bianchi; Neal A Ladwa; Ying-Jie Wang; Renee Hrin; Maria Veneziano; Fabio Bonelli; Thomas J Ketas; John P Moore; Michael D Miller; Antonello Pessi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

Review 4.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 5.  Materials and methods for delivery of biological drugs.

Authors:  Alexander N Zelikin; Carsten Ehrhardt; Anne Marie Healy
Journal:  Nat Chem       Date:  2016-10-21       Impact factor: 24.427

Review 6.  Revisiting amino acids and peptides as anti-glycation agents.

Authors:  H Chilukuri; M J Kulkarni; M Fernandes
Journal:  Medchemcomm       Date:  2018-02-12       Impact factor: 3.597

7.  A cholesterol tag at the N terminus of the relatively broad-spectrum fusion inhibitory peptide targets an earlier stage of fusion glycoprotein activation and increases the peptide's antiviral potency in vivo.

Authors:  Chuan-Gen Li; Wang Tang; Xiao-Jing Chi; Zhi-Ming Dong; Xi-Xi Wang; Xiao-Jia Wang
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

8.  Peptide lipidation stabilizes structure to enhance biological function.

Authors:  Brian P Ward; Nickki L Ottaway; Diego Perez-Tilve; Dejian Ma; Vasily M Gelfanov; Matthias H Tschöp; Richard D Dimarchi
Journal:  Mol Metab       Date:  2013-09-05       Impact factor: 7.422

9.  Lipid-conjugated Smac analogues.

Authors:  Ewa D Micewicz; Josephine A Ratikan; Alan J Waring; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-09-08       Impact factor: 2.823

Review 10.  Liraglutide in the management of type 2 diabetes.

Authors:  Estela Wajcberg; Amatur Amarah
Journal:  Drug Des Devel Ther       Date:  2010-10-22       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.